RxDoctor Payments DataLook up a doctor →

RETHYMIC: payments to doctors

Payments that named RETHYMIC as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$805K
Providers
57
Transactions
265
Average per transaction
$3,039

The per-transaction average — $3,039 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 57 providers the average total is $14,129, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Sumitomo Pharma America, Inc.$723,26089.8%
Enzyvant Therapeutics, Inc.$82,11810.2%
← All drugs & devices